基本分析
透過季節調整季營收，判斷美股整體趨勢，但注意股價有時候領先基本面的數據，應搭配其他領先指標判斷。
基本資料
個股的基本資料，以及所屬的類股和產業。
公司介紹
業務介紹
Ionis Pharmaceuticals, Inc.（Ionis製藥公司）在美國發現和開發針對RNA的治療藥物。該公司提供SPINRAZA（斯賓拉扎）用於小兒和成人患者的脊髓性肌肉萎縮症（SMA）；TEGSEDI（泰格賽迪）用於成人遺傳性轉甲狀腺素介導的淀粉樣蛋白病多發性神經病；以及WAYLIVRA（威利瓦）用於家族性乳糜微粒症候群和家族性部分脂肪萎縮症的治療。它還正在開發多種適應症的藥物，目前處於第3階段研究，包括Eplontersen（依普隆特森）作為每月一次的皮下注射自我治療，用於治療所有類型的TTR淀粉樣蛋白病；Olezarsen（奧利扎森）用於嚴重高三酸甘油酯血症（SHTG）患者；Donidalorsen（多尼達洛森）用於遺傳性血管性水腫患者；ION363（依昂363）用於肌萎縮性脊髓側索硬化症患者；Pelacarsen（佩拉卡森）用於已確診心血管疾病且低密度脂蛋白(a)升高的患者；以及Tofersen（托費森）用於抑制超氧化物歧化酶1的產生。此外，該公司還開發用於代謝性疾病、傳染病、腎臟疾病、眼科疾病和癌症的藥物。它與Biogen Inc.（必健公司）有戰略合作；與AstraZeneca、Bayer AG、GlaxoSmithKline plc、Novartis AG、Roche、Janssen Biotech, Inc.和Flamingo Therapeutics, Inc.有合作和許可協議。Ionis Pharmaceuticals, Inc.成立於1989年，總部位於加利福尼亞州卡爾斯巴德。
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
